<DOC>
	<DOCNO>NCT01979913</DOCNO>
	<brief_summary>Increased intraocular pressure ( IOP ) identify important risk factor development progression glaucoma . Data large interventional study show decrease IOP associate reduce risk progression disease . This underlines importance potent save IOP lower therapy . The introduction preservative free tafluprost offer new treatment possibility use potent topical prostaglandin analogue without disadvantage co-administered preservative . The current study seek investigate effect 8 week therapy preservative free tafluprost intraocular pressure patient ocular hypertension primary open angle glaucoma IOP 30 mmHg .</brief_summary>
	<brief_title>An Open , Non-randomized Pilot Study Effect Preservative Free Tafluprost ( SaflutanÂ® Augentropfen ) Patients With Ocular Hypertension Primary Open Angle Glaucoma With Uncontrolled Intraocular Pressure 30 mmHg More</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Glaucoma</mesh_term>
	<mesh_term>Glaucoma , Open-Angle</mesh_term>
	<mesh_term>Ocular Hypertension</mesh_term>
	<criteria>Men woman age 18 year Diagnosed primary open angle glaucoma IOP 30mmHg least 1 eye visit 1 8 Patients ocular hypertension define IOP 30mmHg normal finding visual field optic nerve head Participation clinical trial 3 week screen visit Severe visual field loss define MD 15 worse Symptoms clinically relevant illness 3 week first study day Presence history severe medical condition interfere study aim judge clinical investigator Presence history severe ocular condition interfere study aim judge clinical investigator Wearing contact lenses Topical treatment ophthalmic drug 4 week precede study except glaucoma medication topical lubricant Ocular infection Ocular surgery 6 month precede study Pregnancy , plan pregnancy lactate Contraindication use topical prostaglandin therapy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>Primary Open Angle Glaucoma</keyword>
	<keyword>Ocular Hypertension</keyword>
	<keyword>Tafluprost</keyword>
	<keyword>Saflutan</keyword>
	<keyword>Intraocular pressure</keyword>
	<keyword>Preservative free</keyword>
	<keyword>Single dose unit</keyword>
</DOC>